TETRAGENEX PHARMACEUTICALS, INC. 4
4 · TETRAGENEX PHARMACEUTICALS, INC. · Filed Jul 30, 2007
Insider Transaction Report
Form 4
SCHACKER MARTIN F
DirectorCo-CEO/ Chairman of the Board
Transactions
- Award
Option
2007-07-26+850,000→ 2,562,000 totalExercise: $1.00→ Common Stock (850,000 underlying)
Footnotes (2)
- [F1]These options are exercisable on 7/26/07.
- [F2]These options expire on 7/26/17.